Walder Wyss advised real estate service provider Ista in connection with the acquisition — by the company’s Swiss subsidiary Ista Swiss — of Blockstrom, a specialist in digital energy data management and ZEV solutions. The Walder
Tags :Robert von Rosen
Freiburg-based bicycle leasing specialist JobRad Group completed the acquisition of MyBikePlan, a Swiss Swiss e-commerce and mobility startup focused on e-bikes. In connection with the deal, Walder Wyss advised JobRad Group, while CMS Switzerland represented
Globally active biopharmaceutical company AstraZeneca has exercised an option to acquire obesity drug startup SixPeaks Bio. In connection with the deal, Lenz & Staehelin represented AstraZeneca, while Walder Wyss advised SixPeaks Bio and its shareholders.
Walder Wyss advised Fielmann Group and tele-ophthalmology platform Ocumeda, as the the first agreed to sell a 10% stake in Ocumenda to Zeiss Vision Care. The deal implied a total company valuation of EUR 100m, with
Walder Wyss advised the Dec Group – a specialist in high-containment processing technologies for the pharmaceutical, chemical, and specialty industries – and its existing shareholders, throughout completion of a financial partnership with ICG, an alternative asset manager
Walder Wyss advised the investors in Mosanna Therapeutics’ Series A financing round EQT Life Sciences and Pivotal bioVenture Partners led the round in question, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning
Walder Wyss advised American translation and language services company TransPerfect throughout its acquisition of Apostroph Group, a Switzerland- and Germany-based language service provider (LSP). The context In connection with the deal, TransPerfect expands its yet
Walder Wyss advised Anklin, a Swiss distributor medical instruments and devices, in transaction that brought the company to become part of German Karl Storz. The parties Reinach-based Anklin is active in the distribution a distributor
Axalta Coating Systems Group has completed the acquisition of André Koch, a well-established provider of car repair and maintenance services. André Koch, previously privately owned, has excelled in the premium segment of the refinish market
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
